Given Imaging Ltd is an Israeli High-tech company. Given Imaging has pioneered the field of swallowable video capsule endoscopy with its PillCam technology. For GI physicians in clinics and hospitals, Given Imaging technology is now being recognized as the gold standard in detecting disease of the small intestine, resulting in more accurate diagnosis of a range of gastrointestinal disorders.

For patients, Given Imaging's PillCam^TM Capsule Endoscope offers the first effective, patient friendly gastrointestinal endoscope on the market.

The first application for visualizing the entire 20-foot long small intestine was cleared for marketing by the European CE and the FDA in 2001 and has been used since then to diagnose a quarter of a million patients in more than 50 countries worldwide. The company plans to leverage its technology as a diagnostic platform for other areas of the gastrointestinal tract including the esophagus, the stomach and the colon. PillCam ESO for visualizing the esophagus was cleared by the European CE and the FDA in 2004, PillCam Colon is in clinical trials and PillCam for the stomach is in development.

Pillcam Capsule Endoscope

Given Imaging's mission is to be the global leader in providing patient-friendly solutions for the gastrointestinal community. Given Imaging possesses core technologies in multiple disciplines, including electronics, micro-optics, wireless communication, sensory and advanced algorithms, which are used in its existing imaging ingestible capsule platform.

Given was founded in 1998 by Mr. Gavriel D. Meron who serves as President and CEO of the company. Given maintains its corporate headquarters, research and development laboratories, and production plant in a newly constructed 25,000 square foot facility in the New Industrial Park in Yoqneam, Israel. North American headquarters are located in Atlanta, GA. and European headquarters are located in Hamburg.

Given Imaging and Nano2Life

Given Imaging is leading an European NEMO consortium as well as the Israeli Bio-Medical Photonics consortium, both are involved in the development of in-vivo immunoassay analysis based on nanoparticles and nano-liposome technology.

The Nano2Life network of excellence is the perfect window to this field for Given Imaging and a good environment for development of Nano applications for bio-diagnostic and bio-sensory.